EU regulators expand use of remote source data verification in clinical trials during the COVID-19 pandemic
The latest update to the European Commission and European Medicines Agency’s guidance on managing clinical trials conducted during the COVID-19 pandemic (V4 04Feb21) expands the use and scope of remote source data verification (rSDV) in clinical trials. Now, in addition to trials involving the treatment or prevention of COVID-19, remote SDV may be considered for […]
Read More "EU regulators expand use of remote source data verification in clinical trials during the COVID-19 pandemic"